Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Eleven Bio's Shares Routed as Dry Eye Drug Flunks Phase 3 Test
Eleven Bio's Shares Routed as Dry Eye Drug Flunks Phase 3 Test
Eleven Bio's Shares Routed as Dry Eye Drug Flunks Phase 3 Test
Submitted by
admin
on May 18, 2015 - 9:05am
Source:
Xconomy
News Tags:
Eleven Biotherapeutics
dry eye disease
EBI-005
Headline:
Eleven Bio's Shares Routed as Dry Eye Drug Flunks Phase 3 Test
Do Not Allow Advertisers to Use My Personal information
